2-([1,2,4]Triazolo[1,5-a]pyridin-2-yl)ethanamine → 7-Chloro-5-methyl-2-(2-[1,2,4]triazolo[1,5-a]pyridin-2-yl-ethyl)-5H-pyrrolo[3,4-c]pyridine-1,3,6-trione
Reaction equation
[N:1]1[C:2]([CH2:10][CH2:11][NH2:12])=[N:3][N:4]2[CH:9]=[CH:8][CH:7]=[CH:6][C:5]=12.[CH3:13][N:14]1[CH:19]=[C:18]([C:20](O)=[O:21])[C:17]([C:23](OC)=[O:24])=[C:16]([Cl:27])[C:15]1=[O:28]>>[Cl:27][C:16]1[C:15](=[O:28])[N:14]([CH3:13])[CH:19]=[C:18]2[C:20](=[O:21])[N:12]([CH2:11][CH2:10][C:2]3[N:1]=[C:5]4[CH:6]=[CH:7][CH:8]=[CH:9][N:4]4[N:3]=3)[C:23](=[O:24])[C:17]=12Participants
3
Procedure
The title compound was prepared in analogy to the process described in Example c1) starting from 2-([1,2,4]triazolo[1,5-a]pyridin-2-yl)ethanamine and compound (4).
Sources & evidence
- ORD record
- ord-460df8075b9545ff9307431e9f4939c2
- Source dataset
- uspto-grants-2015_10
- Patent number
- US09163019B2
Reaction notes
Loading…